High volatility isn’t a reason to flee the markets says James Norrington. Instead investors should read fear signals as a prompt to think about the proportions of their allocation in the most expensive markets. Read this week's cover story.
Redx Pharma (REDX) is facing an uphill struggle to get its finances in order. The biotech group's shares have been suspended after Liverpool City Council called in the administrators when the group failed to repay a loan. If and when the shares resume trading, Megan Boxall thinks there's little hope for the share price.
Elsewhere, two of our readers face the rare problem of having £700,000 of spare cash. Kate Beioley helps them work out the best way to invest their capital by focusing on objectives and strategies.
On this week's Companies & Markets podcast editor John Hughman speaks to Alex Newman about the problems at oil services group Petrofac (PFC), and rounds up the rest of the week's big market stories with news editor Emma Powell. Listen here.
To read all of this week's articles, click here.
